CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>

Malignant T-cell transformation after chimeric antigen receptor (CAR) T-cell therapy has been described, but the contribution of CAR integration to oncogenesis is not clear. Here we report a case of a T-cell lymphoma harboring a lentiviral integration in a known tumor suppressor, <i>TP53</i>, which developed in a patient with multiple myeloma after B-cell maturation antigen (BCMA) CAR T-cell therapy.

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2025-02-05
DOI
https://doi.org/10.1056/nejmoa2411507
Citations
58
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
60.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53

Saad Z. Usmani, Sneha Mitra, J.K. Everett, Frederic D. Bushman et al.
58 citations
New England Journal of Medicine
CAR-T cell therapy research
60.63
article

CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53

Saad Z. Usmani, Sneha Mitra, J.K. Everett, Frederic D. Bushman, Gunjan L. Shah, Özgür Can Eren, Ahmet Doǧan, Karlo Perica, Utsav Patel, Nicholas D. Socci, Michael Scordo, Ruchi Patel, Maria E. Arcila, Sham Mailankody, Steven M. Horwitz, Sergio A. Giralt, Aoife M. Roche, Laetitia Borsu, Dylan Domenico, Elli Papaemmanuil, Gunes Gundem, Christina C. Leslie, Angelina Petrichenko, Nayan Jain, Jae H. Park, Michel Sadelain
article en
58 citations

Abstract

Malignant T-cell transformation after chimeric antigen receptor (CAR) T-cell therapy has been described, but the contribution of CAR integration to oncogenesis is not clear. Here we report a case of a T-cell lymphoma harboring a lentiviral integration in a known tumor suppressor, <i>TP53</i>, which developed in a patient with multiple myeloma after B-cell maturation antigen (BCMA) CAR T-cell therapy.

New England Journal of MedicineVol. 392(6)
Memorial Sloan Kettering Cancer Center (US), Cornell University (US), Molecular Oncology (United States) (US), University of Pennsylvania (US)
Leukemia and Lymphoma Society, University of Pennsylvania, Memorial Sloan-Kettering Cancer Center, National Institutes of Health, Center for AIDS Research, University of Washington, National Cancer Institute
Zero hunger
Openalex Percentile: Top 0%
CAR-T cell therapy research
60.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.